Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Operating Cash Flow Growth
36.55%
TTM · Period ending:
TEVA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported36.55%period ending
Latest reported36.55%period ending
TEVA TTM Cash from Operations YoY % (29.49% → 36.55%)
Year-over-year change
High-resolution chart · PNG
TEVA operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 36.5468% | |
| 35.387% | |
| 32.2374% | |
| -42.5647% | |
| 19.0068% | |
| -8.8553% | |
| -8.845% | |
| 60.4149% | |
| -31.0914% | |
| -7.0281% | |
| -13.9623% | |
| 7.8285% | |
| 60.0567% | |
| 29.4627% | |
| 99.2481% | |
| 59.4354% | |
| 134.8115% | |
| 128.0632% | |
| -34.375% | |
| -52.7056% | |
| -68.7023% | |
| -46.2274% | |
| 62.5668% | |
| 146.6205% | |
| 114.1159% | |
| -11.3936% | |
| -69.4195% | |
| -82.2897% | |
| -82.9793% | |
| -76.5718% | |
| -30.2538% | |
| -13.1894% | |
| -3.4904% | |
| 4.9549% | |
| -32.8804% | |
| -30.6925% | |
| -18.8231% | |
| -22.376% | |
| -5.72% | |
| -4.6487% | |
| -16.0233% | |
| -0.3403% | |
| 8.0944% | |
| 35.5047% | |
| 87.1691% | |
| 84.0752% | |
| 58.3874% | |
| 4.8274% | |
| -30.226% | |
| -38.3286% | |
| -29.1995% | |
| -9.6089% | |
| 19.3155% | |
| 23.2581% | |
| 10.5951% | |
| 16.1502% | |
| -14.6681% | |
| -3.8554% | |
| -0.0484% | |
| -4.5853% | |
| 18.2627% | |
| 17.6971% | |
| 22.6208% | |
| 17.9025% | |
| 24.4951% | |
| 9.5712% | |
| 4.3949% | |
| 20.5914% | |
| 26.3895% | |
| 56.2136% | |
| 78.2129% | |
| 38.1126% | |
| -2.575% | |
| -9.1911% | |
| -11.9048% | |
| 30.8946% | |
| 117.7087% | |
| 67.3182% | |
| 50.219% | |
| 3.6654% | |
| -23.8513% | |
| 2.1088% | |
| 9.7053% | |
| 42.8653% | |
| 89.0747% | |
| 105.3193% | |
| 99.2978% | |
| 123.8258% | |
| 88.3049% | |
| 42.3509% | |
| 77.1558% | |
| 24.658% | |
| 20.8708% | |
| 57.1016% | |
| 29.4902% |